Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc

Bullboard Posts

Comment by Onedaylateon Nov 11, 2016 9:27pm

109 Views

Post# 25452388

RE:Clone Gold Results from Lab

News release on Oct 21 stated results in 4-6 weeks. So about the end of Nov or early Dec. But this company has a track record of delaying bad news. So if it is good news they will be on time. Otherwise look for them to start hypeing diamond property, and then give the results later in Jan. That was the pattern for the PLS results.
I am long MKN, sigh......very long!

Bullboard Posts

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload